Journal of Pharmaceutical Analysis (Mar 2024)

Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway

  • Congyu Ma,
  • Ning Sheng,
  • Jun Wu,
  • Lulu Wang,
  • Jiandong Jiang,
  • Haibo Yu,
  • Jinlan Zhang

Journal volume & issue
Vol. 14, no. 3
pp. 435 – 438

Abstract

Read online

No abstracts available.